Friday, October 31, 2014 Last update: 7:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Foundation Medicine to Present at the Wedbush 2014 Life Sciences Conference

Companies mentioned in this article: Foundation Medicine, Inc.

CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- Foundation Medicine, Inc. (NASDAQ:FMI) today announced that Jason Ryan, senior vice president finance, is scheduled to present at the Wedbush 2014 Life Sciences Conference on Wednesday, August 13, 2014, at 12:45 p.m. E.T. in New York City.

A live, listen-only webcast of the presentation may be accessed by visiting the investors section of the company’s website at investors.foundationmedicine.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the company's website for two weeks following the presentation.

About Foundation Medicine

Foundation Medicine (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company’s clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies, sarcomas and pediatric cancers, provide a fully informative genomic profile to identify the molecular alterations in a patient’s cancer to help physicians in matching them with relevant targeted therapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine® and FoundationOne® are registered trademarks and Interactive Cancer Explorer™ is a trademark of Foundation Medicine, Inc.


Copyright © Business Wire 2014
Contact:

Media Contact:
Pure Communications, Inc.
Dan Budwick, 973-271-6085
dan@purecommunicationsinc.com
or
Investor Contact:
Khaled Habayeb, 617-418-2283
ir@foundationmedicine.com